Zymeworks Inc. (ZYME)
NASDAQ · Healthcare
Zymeworks Inc. annual/quarterly shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Zymeworks Inc. shareholder equity for the quarter ending December 31, 2025 were 268.5M, a 20.74% decrease year-over-year.
- Zymeworks Inc. shareholder equity for 2025 were 268.5M, a 20.74% decrease from 2024.
- Zymeworks Inc. shareholder equity for 2024 were 338.8M, a 27.12% decrease from 2023.
- Zymeworks Inc. shareholder equity for 2023 were 464.8M, a 5.71% decrease from 2022.
- Zymeworks Inc. shareholder equity for 2022 were 493.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Zymeworks Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $269 |
| 2024 | $339 |
| 2023 | $465 |
| 2022 | $493 |
| 2021 | $249 |
| Zymeworks Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $269 |
| 2024-12-31 | $339 |
| 2023-12-31 | $465 |
| 2022-12-31 | $493 |
| 2021-12-31 | $249 |
Zymeworks Inc. Shareholder Equity — FAQ
Zymeworks Inc. (ZYME) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZYME's shareholder equity history?
The chart and table above show Zymeworks Inc.'s shareholder equity by year and by quarter, including the growth rate.